Your position:
m.limatoxi.com
>>
EN
>>
Pharmaceutical News
>>
Company
>>
Simcere completes Endostar phase IV study
>> article
Simcere completes Endostar phase IV study
Editor:lizz Clicks:
0
Date:2010-3-29 9:11:46
Keyword:
Simcere
Healthoo Information:
The study was the first phase-IV clinical study for a Class-1 new drug in China. This is the largest clinical study ever conducted in China.
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Merck and Simcere launch JV in China
Simcere collaborates with BMS to develop ...
Simcere RA medication gets approval
Merck and Simcere signed agreement to es...
Celgen gets new drug approval for Qiangk...
Simcere obtains right of BMS-817378 in C...
Simcere and BMS partner to develop oncol...
Simcere acquires additional satke in Boda
Simcere Pharma make response to vaccines ...
Simcere acquires production approval for Rosu...
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
